Company: PTPI
Filing Date: 2025-02-14
Form Type: S-1/A
Source: 0001410578-25-000137
Chunk: 263

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-02-14
Form: S-1/A
Chunk 263
---
              4,760 | ​ | ​ |           111,476 |
| Total prepaid expenses and other current assets | ​ | $ |          1,826,319 | ​ | $ |         2,033,980 |

6) Intangible Assets

Intangible Assets are comprised of the following:

| ​                             | ​ | ​ |          ​ |
|:------------------------------|:--|:--|-----------:|
| Balance at December 31, 2022  |   | $ | 12,244,484 |
| Amortization expense          | ​ |   | -3,272,747 |
| Balance at December 31, 2023  | ​ |   |  8,971,737 |
| Amortization expense          | ​ | ​ | -2,145,850 |
| Balance at September 30, 2024 | ​ | $ |  6,825,887 |

F-43

The future annual amortization related to the Company’s intangible assets is as follows as of September 30, 2024:

| ​                         | ​ | ​ |         ​ |
|:--------------------------|:--|:--|----------:|
| 2024 (remaining 3 months) |   | $ |   654,774 |
| 2025                      |   | ​ | 1,754,329 |
| 2026                      |   | ​ | 1,442,186 |
| 2027                      |   | ​ | 1,212,871 |
| 2028                      | ​ | ​ |   996,636 |
| Thereafter                |   | ​ |   765,091 |
| Total                     | ​ | $ | 6,825,887 |

The intangible assets held by the Company are the Stendra® product, Timm Medical product, and PTV product and are being amortized over their estimated useful lives of , , and , respectively. The carrying value of the Stendra® product, Timm Medical product, and PTV product as of September 30, 2024, are $ million, $ million and $ million, respectively. The carrying value of the Stendra® product, Timm Medical product, and PTV product as of December 31, 2023, were $ million, $ million and $ million, respectively. During the nine months ended September 30, 2024, and 2023, respectively, the Company